OncoSec Medical Inc (ONCSQ)

[salgovernale69]

If you've done any due diligence and paid any attention to ONCS over the last several weeks, you'd realize that it's almost certainly not the case here. The news has been nothing but good in terms of the science and the addition of high profile doctors who would never affiliate their good names with a company that they thought was "playing octopus."

There was a dilution, but as far as we know it was done to strengthen the company's position for partnership negotiations and to help fund the growing R&D Department. This dilution was also a direct offering to "highly respected" biotech investors, per the CEO. That dilution has led to this short-term price hit but once the dust settles and final Phase 2a data is released followed by Phase 2b trial plans, I expect that those buying at these prices will be handsomely rewarded.